Overview

Effect of Sulodexide in Overt Diabetic Nephropathy

Status:
Terminated
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether sulodexide is effective in slowing or preventing the progression of diabetic kidney disease.
Phase:
Phase 4
Details
Lead Sponsor:
Keryx Biopharmaceuticals
Collaborator:
Collaborative Study Group (CSG)
Treatments:
Glucuronyl glucosamine glycan sulfate